See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Alnylam Pharmaceuticals, Inc. (ALNY) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Alnylam Pharmaceuticals, Inc. (ALNY) - free report >>
Image: Bigstock
New Strong Sell Stocks for March 6th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Amerisafe, Inc. (AMSF - Free Report) is an insurance holding company. The Zacks Consensus Estimate for its current year earnings has been revised 9.3% downward over the last 30 days.
Alnylam Pharmaceuticals, Inc. (ALNY - Free Report) is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 20.9% downward over the last 30 days.
Archrock Partners, L.P. is a natural gas contract operations services provider. The Zacks Consensus Estimate for its current year earnings has been revised 10.8% downward over the last 30 days.
Cheniere Energy Partners, L.P. (CQP - Free Report) is an operator of regasification facilities. The Zacks Consensus Estimate for its current year earnings has been revised 1.4% downward over the last 30 days.
Cincinnati Bell Inc. is a diversified telecommunications and technology services provider. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.
View the entire Zacks Rank #5 List.